Chimeric antigen receptor T cell immunotherapy in colorectal cancer: primetime yet?

Clicks: 128
ID: 278443
2024
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #27 of 39 articles by views in ANZ journal of surgery

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
vanguardia2024chimericanz Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Vanguardia, Maria Kristina;Hassum, Hannah;Roth, Sara;Brown, Wendy;Kong, Joseph Cherng Huei;
Journal ANZ journal of surgery
Year 2024
DOI
10.1111/ans.18926
URL
Keywords
Texture analysis prostate cancer dwi total variation penalty function benign prostatic hyperplasia dki ivim

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.